| Entry |
|
|---|
| Name |
Betamethasone butyrate propionate (JAN);
Antebate (TN) |
|---|
| Formula |
C29H39FO7
|
|---|
| Exact mass |
518.268
|
|---|
| Mol weight |
518.6142
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
Dermatological agent
DG03243 Atopic dermatitis agent
|
|---|
| Remark |
| Therapeutic category: | 2646 |
| Product (DG00095): | D00244<JP> D00972<JP> D01357<JP/US> D01637<JP/US> D02032<JP> |
| Product (mixture): | D10788<JP> |
|
|---|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07225 | Glucocorticoid and mineralocorticoid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally
A07EA04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA Corticosteroids
C05AA05 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07XC Corticosteroids, potent, other combinations
D07XC01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD Corticosteroids
R01AD06 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BA Glucocorticoids
R03BA04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA06 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01CB04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S02 OTOLOGICALS
S02B CORTICOSTEROIDS
S02BA Corticosteroids
S02BA07 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03B CORTICOSTEROIDS
S03BA Corticosteroids
S03BA03 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
2646 Adrenocorticotropic hormones
D02032 Betamethasone butyrate propionate (JAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00095 Betamethasone
D02032 Betamethasone butyrate propionate
Dermatological agent
DG03243 Atopic dermatitis agent
D02032 Betamethasone butyrate propionate
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D02032 Betamethasone butyrate propionate
Dermatological agent
DG03243 Atopic dermatitis agent
D02032 Betamethasone butyrate propionate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D02032 Betamethasone butyrate propionate (JAN) <JP>
Topical steroids potency [br08317.html]
Classification in Japan
D02032
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00095 Betamethasone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 37
1 C2x C 15.6561 -19.4690
2 C5x C 15.6561 -20.8194
3 C2x C 16.8256 -21.4948
4 C2y C 17.9952 -20.8194
5 C1z C 17.9952 -19.4690
6 C2x C 16.8256 -18.7937
7 C1x C 19.1647 -21.4948
8 C1x C 20.3344 -20.8194
9 C1y C 20.3344 -19.4690
10 C1z C 19.1647 -18.7937
11 C1y C 21.5039 -18.7937
12 C1z C 21.5039 -17.4432
13 C1x C 20.3344 -16.7679
14 C1y C 19.1647 -17.4432
15 C1x C 23.8430 -18.7937
16 C1y C 23.8430 -17.4432
17 C1z C 22.6735 -16.7679
18 C1a C 25.2197 -17.4517
19 C5a C 22.6737 -15.0019
20 C1a C 21.4866 -16.0984
21 O1a O 17.9476 -16.7404
22 C1a C 17.9831 -18.0546
23 O5x O 14.4453 -21.5185
24 X F 19.1493 -20.2006
25 O7a O 23.9078 -16.0487
26 O5a O 23.9029 -14.2923
27 C1b C 21.4828 -14.2991
28 O7a O 20.2708 -14.9989
29 C7a C 19.0588 -14.2991
30 C1b C 17.8467 -14.9989
31 O6a O 19.0588 -12.8996
32 C1a C 16.6320 -14.2975
33 C7a C 26.0073 -16.0487
34 O6a O 26.7103 -17.2661
35 C1b C 26.6970 -14.8538
36 C1b C 28.0922 -14.8536
37 C1a C 28.7947 -13.6363
BOND 40
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 16 18 1 #Up
22 17 19 1 #Up
23 12 20 1 #Up
24 14 21 1 #Up
25 5 22 1 #Up
26 2 23 2
27 10 24 1 #Down
28 17 25 1 #Down
29 19 26 2
30 19 27 1
31 27 28 1
32 28 29 1
33 29 30 1
34 29 31 2
35 30 32 1
36 25 33 1
37 33 34 2
38 33 35 1
39 35 36 1
40 36 37 1
|
|---|
